The relatively high frequency of treatment - related keywords, including “chemotherapy” (30 occurrences), “targeted therapy” (27 occurrences), “PD - 1” (25 occurrences), “PD - L1” (35 occurrences), “immune checkpoint inhibitor” (20 occurrences), “PARP inhibitor” (19 occurrences), implies the continuous exploration of various treatment strategies for ovarian cancer. The gene discussed is RPL17; the disease is ovarian carcinoma.